全文获取类型
收费全文 | 14492篇 |
免费 | 628篇 |
国内免费 | 150篇 |
专业分类
耳鼻咽喉 | 525篇 |
儿科学 | 1888篇 |
妇产科学 | 148篇 |
基础医学 | 1022篇 |
口腔科学 | 184篇 |
临床医学 | 1532篇 |
内科学 | 1716篇 |
皮肤病学 | 128篇 |
神经病学 | 744篇 |
特种医学 | 396篇 |
外科学 | 2410篇 |
综合类 | 777篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 2329篇 |
眼科学 | 118篇 |
药学 | 704篇 |
8篇 | |
中国医学 | 142篇 |
肿瘤学 | 497篇 |
出版年
2023年 | 533篇 |
2022年 | 776篇 |
2021年 | 991篇 |
2020年 | 689篇 |
2019年 | 928篇 |
2018年 | 912篇 |
2017年 | 569篇 |
2016年 | 541篇 |
2015年 | 521篇 |
2014年 | 1077篇 |
2013年 | 975篇 |
2012年 | 697篇 |
2011年 | 768篇 |
2010年 | 594篇 |
2009年 | 636篇 |
2008年 | 573篇 |
2007年 | 460篇 |
2006年 | 390篇 |
2005年 | 342篇 |
2004年 | 241篇 |
2003年 | 151篇 |
2002年 | 135篇 |
2001年 | 152篇 |
2000年 | 144篇 |
1999年 | 97篇 |
1998年 | 82篇 |
1997年 | 88篇 |
1996年 | 78篇 |
1995年 | 53篇 |
1994年 | 56篇 |
1993年 | 36篇 |
1992年 | 38篇 |
1991年 | 31篇 |
1990年 | 30篇 |
1989年 | 37篇 |
1988年 | 25篇 |
1986年 | 25篇 |
1985年 | 81篇 |
1984年 | 88篇 |
1983年 | 60篇 |
1982年 | 77篇 |
1981年 | 67篇 |
1980年 | 60篇 |
1979年 | 63篇 |
1978年 | 48篇 |
1977年 | 33篇 |
1976年 | 65篇 |
1975年 | 37篇 |
1974年 | 45篇 |
1973年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
4.
5.
《Journal of pediatric surgery》2023,58(5):856-861
Background/PurposeA small number of Hirschsprung disease (HD) patients develop inflammatory bowel disease (IBD)-like symptoms after pullthrough surgery. The etiology and pathophysiology of Hirschsprung-associated IBD (HD-IBD) remains unknown. This study aims to further characterize HD-IBD, to identify potential risk factors and to evaluate response to treatment in a large group of patients.MethodsRetrospective study of patients diagnosed with IBD after pullthrough surgery between 2000 and 2021 at 17 institutions. Data regarding clinical presentation and course of HD and IBD were reviewed. Effectiveness of medical therapy for IBD was recorded using a Likert scale.ResultsThere were 55 patients (78% male). 50% (n = 28) had long segment disease. Hirschsprung-associated enterocolitis (HAEC) was reported in 68% (n = 36). Ten patients (18%) had Trisomy 21. IBD was diagnosed after age 5 in 63% (n = 34). IBD presentation consisted of colonic or small bowel inflammation resembling IBD in 69% (n = 38), unexplained or persistent fistula in 18% (n = 10) and unexplained HAEC >5 years old or unresponsive to standard treatment in 13% (n = 7). Biological agents were the most effective (80%) medications. A third of patients required a surgical procedure for IBD.ConclusionMore than half of the patients were diagnosed with HD-IBD after 5 years old. Long segment disease, HAEC after pull through operation and trisomy 21 may represent risk factors for this condition. Investigation for possible IBD should be considered in children with unexplained fistulae, HAEC beyond the age of 5 or unresponsive to standard therapy, and symptoms suggestive of IBD. Biological agents were the most effective medical treatment.Level of EvidenceLevel 4 相似文献
6.
《Vaccine》2022,40(18):2525-2527
7.
8.
9.
《Vaccine》2021,39(35):4964-4972
This article applies a qualitative approach to the 2017 dengue vaccine controversy involving Sanofi Pasteur’s Dengvaxia to understand vaccine hesitancy and related anxieties in contemporary Philippines. Through a multisited project that investigated the health aspirations and lived experiences of low- and middle-income Filipinos across urban and rural Philippines, this article distills the perspectives of both ordinary community members and health workers in local and national capacities regarding the controversy—and how it altered their perceptions toward vaccines, health care, and government. Our study reveals widespread mistrust and fear in the communities toward both the state and health institutions following the controversy, with frontline health workers bearing the brunt of the communities’ apprehensions, and the media partly responsible in fomenting these fears. Given the repetitive nature of health and vaccine controversies, this article suggests the importance of responsible journalism, well-calibrated crisis communications, and a people-centered health paradigm that involves exploring local contexts of vaccine hesitancy and mining people’s lived experiences in tackling present and future health crises—especially now in the advent of COVID-19 vaccinations. 相似文献